Sogroya Market Report 2026

Sogroya Market Overview

• The Sogroya market growth in the historic period has been driven by improved diagnosis of adult growth hormone deficiency, expansion of endocrinology specialty care • Market expansion is supported by increasing demand for simplified hormone replacement regimens, rising focus on quality-of-life improvement • Growth Driver: Increasing Demand For Hormone Replacement Therapy Driving Market Growth Due To Rising Hormonal Imbalances • Market Trend: Regulatory Approvals Driving Innovation And Accessibility In The Sogroya Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sogroya Market?

Sogroya (somapegsomatropin) is a long-acting growth hormone treatment used for the treatment of adults with growth hormone deficiency (GHD). It is designed to provide the benefits of growth hormone replacement therapy with the convenience of once-weekly injections, improving patient adherence to treatment. The main indications of the sogroya include adult growth hormone deficiency, and pediatric growth hormone deficiency. Adult growth hormone deficiency (AGHD) refers to a medical condition in which the body does not produce enough growth hormone (GH) after the typical growth period in childhood. The various formulations include subcutaneous injectable, and pre-filled syringes are distributed through various channels such as retail pharmacies, and online pharmacies and several end users include hospital, clinicals, and ambulatory care.

What Is The Sogroya Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for simplified hormone replacement regimens, rising focus on quality-of-life improvement, expansion of home-based hormone therapy, growing investments in long-acting biologics, increasing physician preference for weekly dosing. Major trends in the forecast period include increasing adoption of long-acting growth hormone replacement, rising demand for weekly adult ghd therapies, growing focus on treatment adherence improvement, expansion of pegylated hormone technologies, enhanced emphasis on patient convenience.

Global Sogroya Market Segmentation

1) By Indication: Adult Growth Hormone Deficiency, Pediatric Growth Hormone Deficiency 2) By Formulation: Subcutaneous Injectable, Pre-Filled Syringes 3) By Distribution Channel: Retail Pharmacies, Online Pharmacies 4) By End User: Hospital, Clinicals, Ambulatory Care

What Are The Drivers Of The Sogroya Market?

The increasing demand for hormone replacement therapy (HRT) is anticipated to boost the growth of the sogroya market going forward. HRT is a medical treatment designed to replace hormones like estrogen and progesterone to address symptoms associated with menopause or hormonal imbalances. Hormone replacement therapy (HRT) is increasing due to the rising prevalence of hormonal imbalances, greater awareness of its benefits, and advancements in medical treatments that make it more accessible and effective for managing conditions such as menopause and growth hormone deficiencies. Sogroya supports hormone replacement therapy by providing a once-weekly treatment option for patients with growth hormone deficiency, helping to restore normal growth hormone levels, improve physical function, and enhance overall quality of life with a convenient and effective dosing regimen. For instance, in October 2025, according to the The National Health Service (NHS) a UK-based government body, in the latest period, approximately 14.7 million hormone replacement therapy (HRT) items were prescribed, representing an 11% increase compared with 2023/24. Therefore, the growing demand for hormone replacement therapy is driving the expansion of the sogroya industry. The increasing pharmaceutical industry investment is expected to propel the sogroya market going forward. Pharmaceutical industry investment refers to the financial resources companies allocate into activities such as research and development, clinical trials, manufacturing capacity, and commercialization to discover, develop, produce, and market new medicines and therapies. the rising pharmaceutical industry investment is increasing due to growing demand for innovative biologic therapies, which pushes companies to allocate more funding toward advanced research and development to meet unmet clinical needs. Sogroya supports pharmaceutical industry investment by offering a differentiated once-weekly growth hormone therapy that strengthens company portfolios, expands market opportunities, and justifies continued funding toward innovative endocrine treatments. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual.Therefore, increasing pharmaceutical industry investment is driving the expansion of the sogroya industry.

Key Players In The Global Sogroya Market

Major companies operating in the sogroya market are Novo Nordisk A/S

Global Sogroya Market Trends and Insights

Key companiesin the sogroya market are increasingly focusing on gaining regulatory approvals to expand its indications and improve accessibility. Regulatory approvals refer to the official authorization by government agencies to ensure a drug's safety, efficacy, and quality before it can be marketed or prescribed. For instance, in April 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for Sogroya, used for the treatment of children aged 2.5 years and older with growth hormone deficiency, making it the first once-weekly growth hormone therapy available for both pediatric and adult patients. This innovative treatment allows for subcutaneous injection just once a week, offering a more convenient alternative to daily injections. The approval is based on the phase 3 REAL4 study, which demonstrated comparable height velocity outcomes between Sogroya and traditional daily somatropin. Common side effects include nasopharyngitis, headache, and injection site reactions.

Regional Insights

North America was the largest region in the sogroya market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Sogroya Market?

The sogroya market consists of sales of syringes and needles, sterile wipes, alcohol swabs, and sharps containers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sogroya Market Report 2026?

The sogroya market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sogroya industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.